Fluorescein Sodium

荧光素钠

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameFluorescein Sodium
Drug Alias Name萤光素钠钠荧光素历设得FluoresciteAlcon +[6] 
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsContrast agentsDiagnostic agentsSubstance-Related Disorders +[17] 
Global Approved IndicationsDiagnostic agents
Approved Indications in ChinaDiagnostic agents
Original Approved Country/TerritoryUnited States
Original Approved Date1976/11/10
Country/TerritoryUnited StatesGermanyUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesTechnical University Of MunichNational Heart, Lung, And Blood Institute (Nhlbi)Uptru Inc +[7] 
Inactive CompaniesUtah State UniversityRoswell Park Cancer InstituteVestan Inc +[5] 
Active IndicationsContrast agentsDiagnostic agentsSubstance-Related Disorders +[7] 
Inactive IndicationsIntestinal PolypsHeart Septal Defects, AtrialFallopian Tube Neoplasms +[10] 

Other Information

ATC CodeS01JA01
Related LinksWikipediaDrugBankKEGG